278 related articles for article (PubMed ID: 11154906)
1. Development of an enteric coating formulation and process for tablets primarily composed of a highly water-soluble, organic acid.
Crotts G; Sheth A; Twist J; Ghebre-Sellassie I
Eur J Pharm Biopharm; 2001 Jan; 51(1):71-6. PubMed ID: 11154906
[TBL] [Abstract][Full Text] [Related]
2. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
Varum FJ; Hatton GB; Freire AC; Basit AW
Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
[TBL] [Abstract][Full Text] [Related]
3. Development and stability evaluation of enteric coated Diclofenac sodium tablets using Sureteric.
Zaid AN
Pak J Pharm Sci; 2012 Jan; 25(1):59-64. PubMed ID: 22186310
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of enteric coated tablets of hot-melt extruded lansoprazole.
Alsulays BB; Kulkarni V; Alshehri SM; Almutairy BK; Ashour EA; Morott JT; Alshetaili AS; Park JB; Tiwari RV; Repka MA
Drug Dev Ind Pharm; 2017 May; 43(5):789-796. PubMed ID: 27486807
[TBL] [Abstract][Full Text] [Related]
5. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
[TBL] [Abstract][Full Text] [Related]
6. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
Lee BJ; Ryu SG; Cui JH
Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of pantoprazole sodium enteric-coated pellets-type tablets].
Chen MM; Wang CR; Jin Y
Yao Xue Xue Bao; 2011 Jan; 46(1):96-101. PubMed ID: 21465814
[TBL] [Abstract][Full Text] [Related]
8. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
9. The preparation of capsaicin-chitosan microspheres (CCMS) enteric coated tablets.
Chen J; Huang GD; Tan SR; Guo J; Su ZQ
Int J Mol Sci; 2013 Dec; 14(12):24305-19. PubMed ID: 24351818
[TBL] [Abstract][Full Text] [Related]
10. Biphasic drug release from film-coated tablets.
Ofori-Kwakye K; Fell JT
Int J Pharm; 2003 Jan; 250(2):431-40. PubMed ID: 12527169
[TBL] [Abstract][Full Text] [Related]
11. Combination of a hot-melt subcoating and an enteric coating for moisture protection of hygroscopic Sennae fructus tablets.
Zier KI; Schultze W; Leopold CS
Pharm Dev Technol; 2019 Dec; 24(10):1210-1217. PubMed ID: 31354006
[TBL] [Abstract][Full Text] [Related]
12. A novel electrostatic dry coating process for enteric coating of tablets with Eudragit® L 100-55.
Qiao M; Zhang L; Ma Y; Zhu J; Xiao W
Eur J Pharm Biopharm; 2013 Feb; 83(2):293-300. PubMed ID: 23183445
[TBL] [Abstract][Full Text] [Related]
13. Diffusion of a freely water-soluble drug in aqueous enteric-coated pellets.
Guo HX; Heinämäki J; Yliruusi J
AAPS PharmSciTech; 2002; 3(2):E16. PubMed ID: 12916953
[TBL] [Abstract][Full Text] [Related]
14. A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine.
Liu F; Lizio R; Meier C; Petereit HU; Blakey P; Basit AW
J Control Release; 2009 Jan; 133(2):119-24. PubMed ID: 18930772
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.
Miller DA; Gamba M; Sauer D; Purvis TP; Clemens NT; Williams RO
Int J Pharm; 2007 Feb; 330(1-2):61-72. PubMed ID: 17034967
[TBL] [Abstract][Full Text] [Related]
16. Characterization of enteric-coated tablets and pellets by two in vitro dissolution methods and by scanning electron microscopy.
Odegårdstuen LI; Bjerknes K; Sande SA; Waaler T
Acta Pharm Nord; 1991; 3(3):163-70. PubMed ID: 1793511
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of poly(styrene-alt-maleic anhydride)-ethanol as enteric coating material.
Lai X; Sun C; Tian H; Zhao W; Gao L
Int J Pharm; 2008 Mar; 352(1-2):66-73. PubMed ID: 18054184
[TBL] [Abstract][Full Text] [Related]
18. Development of a multiple-unit tablet containing enteric-coated pellets.
Dreu R; Ilić I; Srčič S
Pharm Dev Technol; 2011 Apr; 16(2):118-26. PubMed ID: 20088675
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of enteric coated tablets of proton pump inhibitor.
Nair AB; Gupta R; Kumria R; Jacob S; Attimarad M
J Basic Clin Pharm; 2010 Sep; 1(4):215-21. PubMed ID: 24825991
[TBL] [Abstract][Full Text] [Related]
20. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]